ACTIVA 37612

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a foreign,health professional,l report with the FDA on 2018-06-27 for ACTIVA 37612 manufactured by Medtronic Neuromodulation.

Event Text Entries

[112540739] This value is the average age of the patients reported in the article as specific patients could not be identified. Please note that the actual date of death was not provided in the literature article; this date is based on the date of article publication. Please note that this date is based off the date that the article was accepted for publication as the event dates were not provided in the published literature. Fitzgerald, pb, segrave, r, richardson, ke, knox, la. , herring, s. , daskalakis, zj. , bittar, rg. A pilot study of bed nucleus of the stria terminalis deep brain stimulation in treatment-resistant depression. Brain stimul. 2018. Doi: 10. 1016/j. Brs. 2018. 04. 013. If information is provided in the future, a supplemental report will be issued.
Patient Sequence No: 1, Text Type: N, H10


[112540740] Summary: studies are increasingly investigating the therapeutic effects of deep brain stimulation (dbs) applied to a variety of brain regions in the treatment of patients with highly treatment refractory depression. Limited research to date has investigated the therapeutic potential of dbs applied to the bed nucleus of stria terminalis (bnst). Objective: the aim of this study was to explore the therapeutic potential of dbs applied to the bnst. Method: five patients with highly treatment resistant depression underwent dbs to the bnst in an open label case series design. Results: bnst dbs resulted in sustained remission of depression in two of the five patients, provided substantial therapeutic improvement two further patients, and had minimal antidepressant effect for the final patient. There were no operative complications and stimulation related side effects were limited and reversible with adjustment of stimulation. However, the time to achieve and complexity of programming required to achieve optimal therapeutic outcomes varied substantially between patients. Conclusion: dbs applied to the bnst as therapeutic potential in patients with highly refractory depression and warrants exploration in larger clinical studies. Reported events: 1. A female patient with bilateral deep brain stimulation (dbs) of the bed nucleus of the stria terminalis (bnst) for depression was a non-responder to stimulation therapy took an overdose with some degree of suicidal intent. The attempt did not occur within 2 weeks of a stimulation adjustment and did not appear to be related to stimulation induced effects. The patient experienced no persistent adverse consequences as a result. However, their electrodes were eventually explanted and new electrodes implanted targeting the subgenual anterior cingulate. They subsequently committed suicide while undergoing open label treatment at the second dbs stimulation target. Patients were implanted with 3387 model leads and 37612 activa rc neurostimulators. It was not possible to ascertain any other specific device information from the article or to match the reported event with any previously reported event.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number3007566237-2018-01917
MDR Report Key7644006
Report SourceFOREIGN,HEALTH PROFESSIONAL,L
Date Received2018-06-27
Date of Report2018-06-27
Date of Event2018-04-19
Date Mfgr Received2018-05-30
Date Added to Maude2018-06-27
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag0
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactLISA WOODWARD CLARK
Manufacturer Street7000 CENTRAL AVENUE NE RCW215
Manufacturer CityMINNEAPOLIS MN 55432
Manufacturer CountryUS
Manufacturer Postal55432
Manufacturer Phone7635263920
Manufacturer G1MEDTRONIC NEUROMODULATION
Manufacturer Street800 53RD AVE NE
Manufacturer CityMINNEAPOLIS MN 554211200
Manufacturer CountryUS
Manufacturer Postal Code554211200
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameACTIVA
Generic NameSTIMULATOR, ELECTRICAL, IMPLANTED, FOR PARKINSONIAN TREMOR
Product CodeMFR
Date Received2018-06-27
Model Number37612
Catalog Number37612
Lot NumberUNKNOWN
OperatorHEALTH PROFESSIONAL
Device AvailabilityN
Device Eval'ed by Mfgr*
Device Sequence No1
Device Event Key0
ManufacturerMEDTRONIC NEUROMODULATION
Manufacturer Address800 53RD AVE NE MINNEAPOLIS MN 554211200 US 554211200


Patients

Patient NumberTreatmentOutcomeDate
101. Death 2018-06-27

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.